Crohn’s & Colitis Congress™

Sessions (15)

P204 - ABILITY OF THERAPEUTIC TREATMENT TO AMELIORATE THE PRO-COLITOGENIC EFFECTS OF IL-15 DURING COLITIS

19 Jan 18
5:30 PM - 7:00 PM

P205 - ALGINATE OLIGOMERS, A POTENTIAL ADJUVANT IN THE TREATMENT OF FISTULIZING CROHN’S DISEASE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P206 - ASSESSING THE COST-EFFECTIVENESS OF EPSTEIN-BARR VIRUS SCREENING IN YOUNG MEN INITIATING COMBINATION THERAPY WITH INFLIXIMAB AND AZATHIOPRINE FOR CROHN’S DISEASE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P207 - CLINICAL PREDICTORS OF RESPONSE TO VEDOLIZUMAB TREATMENT IN CROHN’S DISEASE

19 Jan 18
5:30 PM - 7:00 PM

P208 - COMPLIANCE OF PREVENTATIVE HEALTH CARE MEASURES IN INFLAMMATORY BOWEL DISEASE: A QUALITY IMPROVEMENT PROJECT (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P209 - EPIDEMIOLOGY OF NON-MELANOMA SKIN CANCERS IN HOSPITALIZED PATIENTS OF INFLAMMATORY BOWEL DISEASE IN USA: INSIGHTS FROM NATIONAL INPATIENT SURVEY (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P210 - GASTROINTESTINAL SYMPTOMS ARE COMMON IN U.S. PATIENTS WITH MODERATE-SEVERE PSORIASIS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P211 - IMPACT OF OBESITY ON FUTURE IBD-RELATED COMPLICATIONS IN A POPULATION-BASED COHORT OF CROHN’S DISEASE (CD) AND ULCERATIVE COLITIS (UC) PATIENTS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P212 - NOVEL ROLE OF INTESTINAL GOBLET CELLS IN INDUCTION OF TOLERANCE AND PROMOTING STABILITY OF REGULATORY T CELLS (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P213 - THE IMPACT OF SMOKING STATUS ON MORTALITY AND OTHER OUTCOMES IN HOSPITALIZED PATIENTS OF INFLAMMATORY BOWEL DISEASE IN UNITED STATES: “THE SMOKER’S PARADOX” (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P214 - TRENDS IN THE INCIDENCE AND OUTCOMES OF CHOLANGITIS IN HOSPITALIZED PATIENTS OF ULCERATIVE COLITIS: NATIONWIDE ANALYSIS 2002-2014 (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P215 - UNDERSTANDING PHENOTYPIC DISTINCTIONS IN SUB-POPULATIONS OF VERY EARLY ONSET- INFLAMMATORY BOWEL DISEASE (Room Poster Hall)

19 Jan 18
5:30 PM - 7:00 PM

P216 - WHAT IS THE RATE OF CHRONIC OPIOID USE AND HOW IT IMPACTS HEALTHCARE UTILIZATION WITHIN AN IBD CLINIC POPULATION

19 Jan 18
5:30 PM - 7:00 PM

29 - METHOTREXATE IS NOT SUPERIOR TO PLACEBO IN MAINTAINING REMISSION IN PATIENTS WITH ULCERATIVE COLITIS – THE MERIT-UC STUDY (Room Pinyon 4/5)

20 Jan 18
9:55 AM - 10:02 AM

30 - USTEKINUMAB LEADS TO CLINICAL RESPONSE AMONG PATIENTS WITH CROHN’S DISEASE OF THE POUCH AND CHRONIC ANTIBIOTIC DEPENDENT POUCHITIS (Room Pinyon 04/05)

20 Jan 18
10:02 AM - 10:09 AM